Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression

Aldo M. RoccaroDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts 02215, USAAntonio SaccoDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USAPatricia MaisoDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USAAbdel Kareem AzabDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USAYu-Tzu TaiDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USAMichaela R. ReaganDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USAFeda AzabHarvard UniversityLudmila M. FloresDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USAFederico CampigottoDana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, Massachusetts, USAEdie WellerDana-Farber Cancer Institute, Department of Biostatistics and Computational Biology, Boston, Massachusetts, USAKenneth C. AndersonDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USADavid T. ScaddenCenter for Regenerative Medicine and Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USAIrene M. GhobrialDana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, Massachusetts, USA
2013en
ABI

Аннотация

BM mesenchymal stromal cells (BM-MSCs) support multiple myeloma (MM) cell growth, but little is known about the putative mechanisms by which the BM microenvironment plays an oncogenic role in this disease. Cell-cell communication is mediated by exosomes. In this study, we showed that MM BM-MSCs release exosomes that are transferred to MM cells, thereby resulting in modulation of tumor growth in vivo. Exosomal microRNA (miR) content differed between MM and normal BM-MSCs, with a lower content of the tumor suppressor miR-15a. In addition, MM BM-MSC-derived exosomes had higher levels of oncogenic proteins, cytokines, and adhesion molecules compared with exosomes from the cells of origin. Importantly, whereas MM BM-MSC-derived exosomes promoted MM tumor growth, normal BM-MSC exosomes inhibited the growth of MM cells. In summary, these in vitro and in vivo studies demonstrated that exosome transfer from BM-MSCs to clonal plasma cells represents a previously undescribed and unique mechanism that highlights the contribution of BM-MSCs to MM disease progression.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 3Использованных источников: 0